Anita Z. Graham - 06 Feb 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
EVP, CHRO
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Anita Z. Graham
Issuer symbol
LH
Transactions as of
06 Feb 2025
Net transactions value
-$58,539
Form type
4
Filing time
10 Feb 2025, 09:06:53 UTC
Previous filing
08 Feb 2024
Next filing
13 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +326 +112% 618 06 Feb 2025 Direct F1
transaction LH Common Stock Tax liability $29,233 -118 -19% $247.74 500 06 Feb 2025 Direct F2
transaction LH Common Stock Options Exercise +369 +74% 869 07 Feb 2025 Direct F1
transaction LH Common Stock Tax liability $29,306 -119 -14% $246.27 750 07 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -326 -19% $0.000000 1,390 06 Feb 2025 Common Stock 326 Direct F1, F3, F4
transaction LH Restricted Stock Unit Options Exercise $0 -369 -27% $0.000000 1,021 07 Feb 2025 Common Stock 369 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
F4 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

Remarks:

On May 17, 2024, LHI became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.